Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1985 2
1986 3
1987 1
1988 5
1989 8
1990 5
1991 5
1992 4
1993 15
1994 12
1995 8
1996 14
1997 20
1998 11
1999 26
2000 30
2001 26
2002 33
2003 43
2004 36
2005 31
2006 48
2007 50
2008 35
2009 38
2010 50
2011 51
2012 39
2013 72
2014 64
2015 68
2016 81
2017 77
2018 71
2019 80
2020 95
2021 81
2022 74
2023 51

Text availability

Article attribute

Article type

Publication date

Search Results

1,317 results

Results by year

Filters applied: . Clear all
Page 1
Defining and treating high-grade B-cell lymphoma, NOS.
Olszewski AJ, Kurt H, Evens AM. Olszewski AJ, et al. Blood. 2022 Sep 1;140(9):943-954. doi: 10.1182/blood.2020008374. Blood. 2022. PMID: 34525177 Free article. Review.
High-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), is a recently introduced diagnostic category for aggressive B-cell lymphomas. ...Recent analyses using gene expression profiling (GEP) revealed that up to 15% of tumors cur …
High-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), is a recently introduced diagnostic category for a …
CAR T-cell therapy for B-cell lymphoma.
Denlinger N, Bond D, Jaglowski S. Denlinger N, et al. Curr Probl Cancer. 2022 Feb;46(1):100826. doi: 10.1016/j.currproblcancer.2021.100826. Epub 2021 Dec 25. Curr Probl Cancer. 2022. PMID: 35012754 Free PMC article. Review.
Anti-CD19 CAR T-cell therapy is now considered standard of care for patients with relapsed or refractory (R/R) aggressive non-Hodgkin's Lymphoma (NHL) after 2 or more lines of therapy. Three second-generation anti-CD19 CAR T-cell products …
Anti-CD19 CAR T-cell therapy is now considered standard of care for patients with relapsed or refractory (R/R) aggressive n …
Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma.
Abramson JS. Abramson JS. Transfus Med Rev. 2020 Jan;34(1):29-33. doi: 10.1016/j.tmrv.2019.08.003. Epub 2019 Aug 29. Transfus Med Rev. 2020. PMID: 31677848 Review.
CAR T-cells are autologous T-cells transduced with a chimeric antigen receptor which targets the modified T-cell against a specified cancer antigen. Anti-CD19 CAR T-cells currently represent transformational therapy for relapsed/refractory aggressive B-cel …
CAR T-cells are autologous T-cells transduced with a chimeric antigen receptor which targets the modified T-cell against a specified …
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment.
Liu Y, Barta SK. Liu Y, et al. Am J Hematol. 2019 May;94(5):604-616. doi: 10.1002/ajh.25460. Am J Hematol. 2019. PMID: 30859597 Free article. Review.
DISEASE OVERVIEW: Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma originating from the germinal center, and it represents a heterogeneous group of diseases with variable outcomes tha …
DISEASE OVERVIEW: Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodg …
Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma.
Moleti ML, Testi AM, Foà R. Moleti ML, et al. Br J Haematol. 2020 Jun;189(5):826-843. doi: 10.1111/bjh.16461. Epub 2020 Mar 6. Br J Haematol. 2020. PMID: 32141616 Free article. Review.
Aggressive B-cell non-Hodgkin lymphoma (B-NHL) accounts for 60% of NHL in children/adolescents. In newly diagnosed Burkitt lymphoma and diffuse large B-cell lymphoma, short intensive multiagent chemother …
Aggressive B-cell non-Hodgkin lymphoma (B-NHL) accounts for 60% of NHL in children/adolesce …
Plasmablastic lymphoma: An update.
Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ. Bailly J, et al. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863. Int J Lab Hematol. 2022. PMID: 36074710 Free PMC article. Review.
Plasmablastic lymphoma (PBL) is a highly aggressive B cell non-Hodgkin lymphoma frequently associated with immunosuppression, particularly human immunodeficiency virus (HIV) infection. ...Laboratory features in PBL may overlap with …
Plasmablastic lymphoma (PBL) is a highly aggressive B cell non-Hodgkin lymphoma frequently …
Double hit and double expressors in lymphoma: Definition and treatment.
Riedell PA, Smith SM. Riedell PA, et al. Cancer. 2018 Dec 15;124(24):4622-4632. doi: 10.1002/cncr.31646. Epub 2018 Sep 25. Cancer. 2018. PMID: 30252929 Free article. Review.
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy for aggressive B-cell lymphomas. The identification of concurrent MYC and B-cell CLL/lymphoma 2 (B …
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy …
The treatment of Burkitt lymphoma in adults.
Crombie J, LaCasce A. Crombie J, et al. Blood. 2021 Feb 11;137(6):743-750. doi: 10.1182/blood.2019004099. Blood. 2021. PMID: 33171490 Free article. Review.
Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma categorized into endemic, sporadic, and immunodeficiency-associated subtypes. ...
Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma categorized into …
Diffuse large B-cell lymphoma.
Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Martelli M, et al. Crit Rev Oncol Hematol. 2013 Aug;87(2):146-71. doi: 10.1016/j.critrevonc.2012.12.009. Epub 2013 Jan 30. Crit Rev Oncol Hematol. 2013. PMID: 23375551 Review.
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults accounting for 31% of all NHL in Western Countries. ...Recent randomized trials suggest that high-dose chemotherapy supported by autologous stem cell transplant (HDC …
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults accounting for 31% of all NHL in …
MALT lymphoma: epidemiology, clinical diagnosis and treatment.
Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C. Violeta Filip P, et al. J Med Life. 2018 Jul-Sep;11(3):187-193. doi: 10.25122/jml-2018-0035. J Med Life. 2018. PMID: 30364585 Free PMC article. Review.
Primary gastric lymphoma (PGL) represents a rare pathology, which can be easily misdiagnosed because of unspecific symptoms of the digestive tract. Histologically, PGL can vary from indolent marginal zone B-cell lymphoma of the mucosa-associated lympho …
Primary gastric lymphoma (PGL) represents a rare pathology, which can be easily misdiagnosed because of unspecific symptoms of the di …
1,317 results